Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol RRM1 contributors: SGE/npt - updated : 15-03-2010
HGNC name ribonucleotide reductase M1
HGNC id 10451
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
19 - 3234 90 792 - Pavloff 1992
EXPRESSION
Type ubiquitous
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Digestivestomach   highly
Reproductivefemale systemuteruscervix highly
Respiratoryrespiratory tractlarynx  highly
cell lineage
cell lines
fluid/secretion
at STAGE
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • an ATP-cone domain
  • HOMOLOGY
    interspecies homolog to murine Rrm1 (97.6pc)
    homolog to rattus Rrm1-ps1 (87.4pc)
    Homologene
    FAMILY
  • ribonucleoside diphosphate reductase large chain family
  • CATEGORY enzyme , tumor suppressor
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm
    basic FUNCTION
  • putative metastasis suppressor (see TSG11D)
  • providing the precursors necessary for DNA synthesis
  • catalyzing the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides
  • involved in tumor invasiveness and metastasis
  • involved in DNA repair during G1 phase (Niida 2010)
  • controls substrate specificity and global on/off enzyme activity
  • CELLULAR PROCESS nucleotide, replication
    nucleotide, repair
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism purine/pyrimidine
    signaling
    deoxyribonucleotides biosynthetic pathway
    a component
  • heterodimer of a large (M1) and a small chain (M2)
  • INTERACTION
    DNA
    RNA
    small molecule nucleotide,
  • ATP binding
  • protein
  • interacts with RRM2B or RRM2
  • binding to KAT5 (Niida 2010)
  • cell & other
    REGULATION
    Other stimulated by ATP and inhibitied by dATP binding to the activity site
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in non-small cell lung cancer with good prognosis
    tumoral     --over  
    associated to overexpression of ERCC1, in lung tumor with excellent outcome
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
  • decreased by tranilast and may be a future novel chemotherapeutic strategy by Gemcitabine against pancreatic cancer (Mitsuno 2010)
  • diagnostic marker of survival in pancreatic cancer patients. only patients with low RRM1 derive benefits from gemcitabine (Akita 2009)
  • ANIMAL & CELL MODELS